Also, GRK2 has been proven to act as a “gatekeeper” for cardiovascular diseases in a GPCR-independent manner (Izzo et al., 2008), and GRK2 knockdown in mice results in age-dependent spontaneous hypertension (Tutunea-Fatan et al., 2015). Here, GRK2 is linked to cardiovascular disorder.